Scipher Medicine

📍 Waltham, United States🗓 Founded 2015👥 122 employees💰 Last funded Oct 2022
Biotechnology Research🌐 sciphermedicine.com
Website LinkedIn
Scipher Medicine is building the future of patient treatment. Most patients who are prescribed blockbuster therapies today don’t respond to the treatment, costing the health care industry billions in wasted drugs while patients continue to suffer. Sciphers platform identifies which drug will work based on the patients fundamental disease biology, and not based on symptoms, disease classification, or medical bias. A simple test predicts which drug he/she will respond to, ensuring that most optimal treatment is prescribed from day one. The molecular data generated by our tests is then used to fuel novel target discovery to address a clear unmet medical need in patients who do not respond to any existing therapy.
5
Total investors
0
Early stage
2
Mid stage
3
Late stage
2015
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
4
United Kingdom
1
Investor activity2018–2022 · investors recorded per year
20181201912021120222
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Scipher Medicine?
Scipher Medicine has 5 investors on record on gritt.io, 2 mid-stage and 3 late-stage investors.
When did Scipher Medicine last raise funding?
The most recent investment in Scipher Medicine recorded on gritt.io was in October 2022.
When was Scipher Medicine founded?
Scipher Medicine was founded in 2015.
What industry is Scipher Medicine in?
Scipher Medicine operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Scipher Medicine based?
Scipher Medicine is headquartered in Waltham, United States.